Epizyme
Patents, Design & Utilities
Last updated:
List of all Epizyme patents 122 in total
Status | Patent |
---|---|
Application | Utility: PEDIATRIC DOSING FOR TREATMENT OF CANCER WITH AN EZH2 INHIBITOR Filling date: 7 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: Methods Of Treating Cancer By Inhibiting SETD2 Filling date: 7 Sep 2025 Issue date: 7 Jan 2021 |
Grant | Utility: Method of treating leukemia Filling date: 7 Sep 2025 Issue date: 5 Jan 2021 |
Application | Utility: INHIBITORS OF HUMAN EZH2, AND METHODS OF USE THEREOF Filling date: 7 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: INJECTABLE FORMULATIONS FOR TREATING CANCER Filling date: 7 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: SUBSTITUTED BENZENE AND 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS Filling date: 7 Sep 2025 Issue date: 19 Nov 2020 |
Grant | Utility: Salt form of a human histone methyltransferase EZH2 inhibitor Filling date: 7 Sep 2025 Issue date: 3 Nov 2020 |
Application | Utility: METHOD OF TREATING CANCER Filling date: 7 Sep 2025 Issue date: 22 Oct 2020 |
Application | Utility: EZH2 INHIBITORS FOR TREATING LYMPHOMA Filling date: 7 Sep 2025 Issue date: 15 Oct 2020 |
Application | Utility: METHODS OF TREATING CANCER Filling date: 7 Sep 2025 Issue date: 15 Oct 2020 |
Grant | Utility: Arginine methyltransferase inhibitors and uses thereof Filling date: 7 Sep 2025 Issue date: 13 Oct 2020 |
Application | Utility: SUBSTITUTED 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS Filling date: 7 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: AMINE-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS AND DERIVATIVES THEREOF Filling date: 7 Sep 2025 Issue date: 8 Oct 2020 |
Grant | Utility: Combination therapy for treating cancer Filling date: 7 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: Method for treating cancer Filling date: 7 Sep 2025 Issue date: 29 Sep 2020 |
Application | Utility: ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 17 Sep 2020 |
Application | Utility: METHOD OF TREATING MEDULLOBLASTOMA WITH AN EZH2 INHIBITOR Filling date: 7 Sep 2025 Issue date: 27 Aug 2020 |
Application | Utility: METHODS OF TREATING CANCER Filling date: 7 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: AMINE-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS, SALTS THEREOF, AND METHODS OF SYNTHESIS THEREOF Filling date: 7 Sep 2025 Issue date: 6 Aug 2020 |
Grant | Utility: Hydrochloride salt form for EZH2 inhibition Filling date: 7 Sep 2025 Issue date: 14 Jul 2020 |
Grant | Utility: Isoxazole carboxamides as irreversible SMYD inhibitors Filling date: 7 Sep 2025 Issue date: 2 Jun 2020 |
Application | Utility: USE OF EZH2 INHIBITORS FOR TREATING CANCER Filling date: 7 Sep 2025 Issue date: 28 May 2020 |
Application | Utility: ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS Filling date: 7 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: METHOD FOR TREATING CANCER Filling date: 7 Sep 2025 Issue date: 21 May 2020 |
Grant | Utility: PRMT5 inhibitors and uses thereof Filling date: 7 Sep 2025 Issue date: 19 May 2020 |
Application | Utility: ISOXAZOLE CARBOXAMIDE COMPOUNDS Filling date: 7 Sep 2025 Issue date: 14 May 2020 |
Application | Utility: METHOD OF TREATING MALIGNANT RHABDOID TUMOR OF THE OVARY (MRTO)/SMALL CELL CANCER OF THE OVARY OF THE HYPERCALCEMIC TYPE(SCCOHT) WITH AN EZH2 INHIBITOR Filling date: 7 Sep 2025 Issue date: 7 May 2020 |
Grant | Utility: CARM1 inhibitors and uses thereof Filling date: 7 Sep 2025 Issue date: 28 Apr 2020 |
Grant | Utility: Arginine methyltransferase inhibitors and uses thereof Filling date: 7 Sep 2025 Issue date: 28 Apr 2020 |
Application | Utility: Substituted Cyclohexylamine Compounds Filling date: 7 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: DOT1L INHIBITORS FOR USE IN THE TREATMENT OF LEUKEMIA Filling date: 7 Sep 2025 Issue date: 16 Apr 2020 |
Application | Utility: COMBINATION THERAPY FOR TREATING CANCER Filling date: 7 Sep 2025 Issue date: 16 Apr 2020 |
Application | Utility: METHODS OF USING EHMT2 INHIBITORS Filling date: 7 Sep 2025 Issue date: 16 Apr 2020 |
Application | Utility: COMBINATION THERAPY FOR TREATING CANCER Filling date: 7 Sep 2025 Issue date: 2 Apr 2020 |
Application | Utility: SUBSTITUTED PYRROLIDINE COMPOUNDS Filling date: 7 Sep 2025 Issue date: 2 Apr 2020 |
Application | Utility: COMBINATION THERAPY FOR TREATING CANCER Filling date: 7 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: INHIBITION OF SMARCA2 FOR TREATMENT OF CANCER Filling date: 7 Sep 2025 Issue date: 5 Mar 2020 |
Grant | Utility: Substituted piperidine compounds Filling date: 7 Sep 2025 Issue date: 3 Mar 2020 |
Application | Utility: COMBINATION THERAPIES WITH EHMT2 INHIBITORS Filling date: 7 Sep 2025 Issue date: 20 Feb 2020 |
Application | Utility: SUBSTITUTED PYRROLIDINE CARBOXAMIDE COMPOUNDS Filling date: 7 Sep 2025 Issue date: 13 Feb 2020 |
Application | Utility: AMINE-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS AND METHODS OF USE THEREOF Filling date: 7 Sep 2025 Issue date: 6 Feb 2020 |
Application | Utility: SUBSTITUTED FUSED BI- OR TRI- HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS Filling date: 7 Sep 2025 Issue date: 6 Feb 2020 |
Application | Utility: COMBINATION THERAPY FOR TREATING CANCER Filling date: 7 Sep 2025 Issue date: 30 Jan 2020 |
Application | Utility: PRMT5 INHIBITORS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: EZH2 INHIBITORS FOR TREATING LYMPHOMA Filling date: 7 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: INHIBITORS OF HUMAN EZH2, AND METHODS OF USE THEREOF Filling date: 7 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: METHOD FOR TREATING CANCER Filling date: 7 Sep 2025 Issue date: 9 Jan 2020 |
Application | Utility: TREATMENT OF LEUKEMIA VIA THE ADMINISTRATION OF DOT1L INHIBITOR PINOMETOSTAT Filling date: 7 Sep 2025 Issue date: 9 Jan 2020 |
Grant | Utility: Combination therapy for treating cancer Filling date: 7 Sep 2025 Issue date: 7 Jan 2020 |
Application | Utility: INJECTABLE FORMULATIONS FOR TREATING CANCER Filling date: 7 Sep 2025 Issue date: 26 Dec 2019 |
Showing 50 to 100 of 122 patents.